Latest Botanix Pharmaceuticals (ASX:BOT) News
Page 3
Page 3 of 3
Botanix’s Sofdra™ Hits AUD 25M with Strong Prescriber Momentum
8 July 2025
Botanix Secures US$30M Debt Facility to Accelerate Sofdra™ Growth
10 June 2025
Botanix Addresses Price Volatility Amid US Drug Pricing Rumors
12 May 2025
Botanix Dismisses US Drug Pricing Impact Amid Trump Executive Order Proposal
12 May 2025
Botanix Pharmaceuticals Launches Sofdra, Eyes Revenue Surge in 2025
31 Jan 2025